The “Before” and “After” photos are breaking the internet. Facebook groups, Reddit threads and gobs of other social media ...

The FTSE 100 has several shares with dividend yields above 7%. But can any of them generate reliable passive income for ...

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth ...

BDCDA sees Novo Nordisk’s aggressive Wegovy price slash a game-changer for obesity: Nandita Vijayasimha, Bengaluru Saturday, November 15, 2025, 08:00 Hrs [IST] The Bangalore Dis ...

Eli Lilly's Mounjaro became India's highest-selling drug in October with ₹100 crore sales. The anti-obesity treatment now ...

The fate of the enhanced Affordable Care Act premium tax credits — initially bolstered during the pandemic — is still unclear ...

The Combating Counterfeit Pharmaceuticals Act, which would amend the Fentanyl Sanctions Act, is authored by Sens. Tom Cotton ...

Wegovy’s key competitor is Eli Lilly’s GLP-1 drug Mounjaro (tirzepatide), which became India’s top-selling medicine in ...

The FDA announced six more awardees for the FDA Commissioner's National Priority Voucher (CNPV) pilot program designed to ...

Among GLP-1 users, more than half said they will eat smaller portions and skip more treats this festive season ...

A trial funded by the Labour Government will ensure obese Scots have free access to Wegovy medication that can cost over £100 a month.